as on September 16, 2025 at 8:38 pm IST
Day's Low
Day's High
1.04%
Downside
1.55%
Upside
52 Week's Low
52 Week's High
32.12%
Downside
204.66%
Upside
Check Nkarta Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$139.9M
EPS (TTM)
-1.3567
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-114.1M
Revenue (TTM)
385.0
Profit Margin
0.00%
Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Nkarta Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $139.9M | -93.91% | NA | 0.00% | |
BUY | $61.1B | 251.26% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.2B | 47.46% | 28.09 | 31.86% | |
BUY | $59.6B | 0.6% | 14.1 | 31.37% |
The Nkarta Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Nkarta Inc investment value today
Current value as on today
₹39,027
Returns
Returns from Nkarta Inc Stock
Dollar Returns*
₹4,867 (+4.87%)
Based on 16 analysts
93.75%
Buy
6.25%
Hold
0.00%
Sell
Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Nkarta Inc. Average target price of $12.4
Get share price movements and forecasts by analysts on Nkarta Inc.
What analysts predicted
84.44%UPSIDE
Target Price
$12.4
Current Price
$1.93
Analyzed by
16 Analysts
Target
$12.40
Nkarta Inc target price $12.4, a slight upside of 84.44% compared to current price of $1.93. According to 16 analysts rating.
Search interest for Nkarta Inc Stock has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 201.8%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 135.7%
Price Dip
In the last 1 month, NKTX stock has moved down by -15.5%
Organisation | Nkarta Inc |
Headquarters | 1150 Veterans Boulevard, South San Francisco, CA, United States, 94080 |
Industry | Health Technology |
CEO | Mr. Paul J. Hastings |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Shawn Rose M.D., Ph.D. | Chief Medical Officer and Head of Research & Development |
Mr. Paul J. Hastings | CEO & Director |
Dr. Nadir Mahmood Ph.D. | President and Principal Accounting & Financial Officer |
Mr. Greg Mann | Vice President of Public Affairs and Investor Relations |
Nkarta Inc share price today is $1.93 as on . Nkarta Inc share today touched a day high of $1.96 and a low of $1.91.
Nkarta Inc share touched a 52 week high of $5.88 on and a 52 week low of $1.31 on . Nkarta Inc stock price today i.e. is trending at $1.93,which is 67.18% down from its 52 week high and 47.33% up from its 52 week low.
Nkarta Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Nkarta Inc (NKTX) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Nkarta Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Nkarta Inc share’s latest price of $1.93 as on September 16, 2025 at 8:38 pm IST, you will get 5.1813 shares of Nkarta Inc. Learn more about
fractional shares .
Nkarta Inc stock has given -93.91% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?